Viewing Study NCT00282620



Ignite Creation Date: 2024-05-05 @ 4:38 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00282620
Status: UNKNOWN
Last Update Posted: 2007-11-20
First Post: 2006-01-25

Brief Title: Magnesium to Reduce Implantable Cardioverter Defibrillator ICD Shocks and Improve Patients Quality of Life
Sponsor: Hartford Hospital
Organization: Hartford Hospital

Study Overview

Official Title: The Adjuvant Magnesium Trial AdMag Assessment if the Impact of Oral Magnesium on ICD Firing and Quality of Life
Status: UNKNOWN
Status Verified Date: 2007-03
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study is being conducted to see if magnesium can reduce the number of shocks patients with ICDs experience and to see if magnesium supplementation improves patients quality of life
Detailed Description: Not all ICD shocks are for ventricular arrhythmias Some patients receive shocks when they have arrhythmias in the atria top chambers of the heart These are called inapproriate shocks but the pain is similar to the pain patients feel with an appropriate shock a shock for a ventricular arrhythmia This study is being conducted to determine if taking magnesium can reduce the number of shocks patients with ICDs experience and to see if magnesium supplementation improves patients quality of life Magnesiums impact of the electrocardiogram ECG and intracellular magnesium concentrations will also be studied

Comparison Magnesium compared to placebo in patients with ICDs to evaluate the number of ICD shocks and patient perceived quality of life

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None